SCHEMBL30912049

CCCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)CC)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 3)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	13/20	0.53

▸	VIPR2	P41587	6/20	0.51

▸	VIPR1	P32241	4/20	0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30912046	0.96	GLP1R (0.50)	GLP1RVIPR2VIPR1
SCHEMBL31612227	0.89	VIPR2 (0.52)	GLP1RVIPR2VIPR1
SCHEMBL30483999	0.89	GLP1R (0.55)	GLP1RVIPR1
SCHEMBL29767364	0.88	GLP1R (0.50)	GLP1RVIPR2VIPR1
SCHEMBL30912047	0.88	RXFP1 (0.49)	VIPR2VIPR1
SCHEMBL29541008	0.88	VIPR2 (0.47)	GLP1RVIPR2VIPR1
SCHEMBL29541058	0.88	VIPR2 (0.47)	GLP1RVIPR2VIPR1
SCHEMBL30912039	0.87	RXFP1 (0.50)	VIPR2VIPR1
SCHEMBL30912040	0.87	RXFP1 (0.50)	VIPR2VIPR1
SCHEMBL31643038	0.87	GLP1R (0.42)	GLP1RVIPR2VIPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240287153-A1	Treating Inflammatory Lung Disease	THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS	2024-08-29	—	—	US	disclosed
US-11993640-B2	Treating inflammatory lung disease	THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US)	2024-05-28	—	—	US	disclosed